BioSpace News Archive

According to a report from Hexa Research, the U.S. medical cannabis market is expected to grow from USD 5.44 Billion to reach USD 19.48 Billion by 2024.

DiscGenics, Inc., a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that Flagg Flanagan, Chairman and CEO, will present at the annual Partnering Forum, part of the Cell & Gene Meeting on the Mesa, on Wednesday, October 3, 2018 at 4:15pm PDT.

Results from a new global survey revealed that more than one-third (36%) of the 310 physicians surveyed do not think they have sufficient information required to make informed decisions on how to sequence treatments for patients with epidermal growth factor receptor mutation-positive (EGFR M+) non-small cell lung cancer

Alteon Health today announced the appointment of Steve Holtzclaw, MD, FACEP, to serve as Chief Executive Officer, effectively immediately. Chris Krubert, MD, who served as CEO on an interim basis, will resume his role as a member of the Board of Directors.

PDL BioPharma, Inc., (“PDL” or the “Company”) (NASDAQ: PDLI) announces that John McLaughlin, PDL’s chief executive officer, will present at the 2018 Cantor Fitzgerald Global Healthcare Conference in New York City. The session will be webcast live and will occur on Wednesday, October 3, 2018, at 12:15pm EDT.

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (“Actinium” or “the Company”), will introduce its next generation targeted lymphodepletion technology for CAR-T therapy on a conference call and webcast today at 4:15 PM ET. Actinium’s next generation targeted lymphodepletion technology is intended to offer a universal solution to certain key challenges facing the CAR-T industry.

Company Preparing for First-in-Human Clinical Trial

BaseCase Portal allows life sciences companies to rapidly deploy mobile apps that use advanced predictive algorithms to individualize patient treatment by making precision-dosing recommendations for example

Alnylam Pharmaceuticals Inc. announced that management will present a company overview at the 2018 Cantor Global Healthcare Conference on Wednesday, October 3, 2018 at 9:45 am ET at the InterContinental New York Barclay Hotel in New York City.

MySpine MC and other Medacta spine innovations will be on display this week at NASS 2018